|
|
Biomarkers May Predict Response to B Cell Depletion Therapy in Patients With Lupus
|
| Link ID |
7455 |
| Title |
Biomarkers May Predict Response to B Cell Depletion Therapy in Patients With Lupus |
| Url |
http://www.medscape.com/viewarticle/578339?src=rss |
| Description |
Among patients with active, refractory systemic lupus erythematosus, clinical responses to B cell depletion therapy (BCDT) were shorter in those had an expanded autoantibody profile and elevated B lymphocyte stimulator (BLyS) levels at baseline, researchers from the US and UK report in the July issue of the Annals of the Rheumatic Diseases. Reuters Health Information |
| Category |
Articles > Pathology and Lab Medicine |
| Keywords |
|
| Date |
Aug 5, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Pathology and Lab Medicine |
| 2. |
Genetic Factors Contribute to Clot Structure and Function
|
|
|
Genetic factors contribute to clot structure and function which, in turn, influence cardiovascular disease risk, according to a report in the December issue of Arteriosclerosis, Thrombosis, and Vascular Biology. Reuters Health Information
|
| 3. |
The Year in Heart Failure
|
|
|
Effective therapies for acute heart failure (HF) syndrome and diastolic heart failure are limited compared to recent advances in genetics and device therapies. What are the next steps for HF therapy?
Journal of the American College of Cardiology
|
| 4. |
Resistance to Temozolomide in Leukemia Tied to DNA Repair Activity
|
|
|
In pediatric patients with refractory or recurrent leukemia, temozolomide resistance is associated with activity of the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT), researchers report in the November 1st issue of the Journal of Clinical Oncology. Reuters Health Information
|
|
|
